Financials Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 12/06/2025 pm IST			5-day change	1st Jan Change
1,484.00 ^DKK	-0.03%		+2.66%	-0.57%

09/06	Genmab A/S Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08:00 AM
09/06	AlphaValue/Baader Europe Keeps Genmab at Buy, Boosts Price Target on Pipeline Strength	MT

Projected Income Statement: Genmab A/S

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	10,111	8,482	14,595	16,474	21,526	23,592	27,276	31,523
Change	-	-16.11%	72.07%	12.87%	30.67%	9.6%	15.62%	15.57%
EBITDA ¹	6,572	3,266	6,719	5,616	7,116	8,250	9,669	12,142
Change	-	-50.3%	105.73%	-16.42%	26.71%	15.94%	17.2%	25.58%
EBIT ¹	6,313	3,018	6,357	5,321	7,003	7,705	9,114	11,132
Change	-	-52.19%	110.64%	-16.3%	31.61%	10.03%	18.28%	22.13%
Interest Paid ¹	-1,558	-702	-680	-942	-1,977	-677.7	-471.6	-488.4
Earnings before Tax (EBT) ¹	5,904	3,983	7,035	5,637	9,164	8,878	10,267	12,740
Change	-	-32.54%	76.63%	-19.87%	62.57%	-3.12%	15.65%	24.09%
Net income ¹	4,758	3,008	5,522	4,352	7,844	6,772	7,943	10,050
Change	-	-36.78%	83.58%	-21.19%	80.24%	-13.67%	17.29%	26.53%
Announcement Date	23/02/21	16/02/22	22/02/23	14/02/24	12/02/25	-	-	-

¹DKK in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	5,451	1,724	2,044	1,581	1,972	2,310	2,619	2,119	3,162	4,087	5,227	2,854	4,198	4,744	4,678	4,143	5,402	5,540	6,441	4,731	5,954	6,291	6,707	5,922	6,712	7,075	7,450
Change	-	-68.37%	18.56%	-22.65%	24.73%	17.14%	13.38%	-19.09%	49.22%	29.25%	27.89%	-45.4%	47.09%	13.01%	-1.39%	-11.44%	30.39%	2.55%	16.26%	-26.54%	25.85%	5.66%	6.62%	-11.71%	13.34%	5.42%	5.29%
EBITDA ¹	4,505	868	1,121	543	802	905	1,016	529	1,263	1,953	2,974	458	1,520	1,739	1,899	823	1,804	2,129	2,275	1,350	2,296	2,300	2,007	2,627	-	-	-
Change	-	-80.73%	29.15%	-51.56%	47.7%	12.84%	12.27%	-47.93%	138.75%	54.63%	52.28%	-84.6%	231.88%	14.41%	9.2%	-56.66%	119.2%	18.02%	6.86%	-40.66%	70.07%	0.19%	-12.75%	30.92%	-	-	-
EBIT ¹	4,497	858	887	532	787	890	809	514	1,247	1,931	2,665	437	1,497	1,717	1,670	801	1,640	2,102	2,191	1,244	2,064	2,224	2,101	1,611	2,622	2,952	3,273
Change	-	-80.92%	3.38%	-40.02%	47.93%	13.09%	-9.1%	-36.46%	142.61%	54.85%	38.01%	-83.6%	242.56%	14.7%	-2.74%	-52.04%	104.74%	28.17%	4.23%	-43.22%	65.91%	7.75%	-5.55%	-23.32%	62.77%	12.59%	10.87%
Charge d'intérêts ¹	-3	-720	-869	-76	-3	-230	-299	-339	-200	-212	71	-435	-17	-41	-449	-13	-399	-698	-775	-297.8	-98.33	-98.33	-98.33	-	-	-	-
Earnings before Tax (EBT) ¹	4,328	671	551	1,424	422	1,171	966	612	2,489	3,272	662	286	1,723	2,702	926	1,716	2,127	1,719	3,602	1,615	2,284	2,320	2,226	1,533	2,757	3,099	3,433
Change	-	-84.5%	-17.88%	158.44%	-70.37%	177.49%	-17.51%	-36.65%	306.7%	31.46%	-79.77%	-56.8%	502.45%	56.82%	-65.73%	85.31%	23.95%	-19.18%	109.54%	-55.17%	41.46%	1.57%	-4.03%	-31.13%	79.8%	12.41%	10.78%
Net income ¹	3,378	530	581	1,096	306	890	716	465	1,891	2,582	584	226	1,357	2,129	640	1,325	1,408	1,266	3,845	1,290	1,679	1,839	1,720	1,227	2,206	2,479	2,747
Change	-	-84.31%	9.62%	88.64%	-72.08%	190.85%	-19.55%	-35.06%	306.67%	36.54%	-77.38%	-61.3%	500.44%	56.89%	-69.94%	107.03%	6.26%	-10.09%	203.71%	-66.44%	30.13%	9.52%	-6.47%	-28.68%	79.77%	12.39%	10.81%
Announcement Date	12/08/20	04/11/20	23/02/21	05/05/21	11/08/21	10/11/21	16/02/22	11/05/22	10/08/22	09/11/22	22/02/23	10/05/23	03/08/23	07/11/23	14/02/24	02/05/24	08/08/24	06/11/24	12/02/25	08/05/25	-	-	-	-	-	-	-

¹DKK in Million

Estimates

Fiscal Period: December	2021 S1	2022 S1	2023 S1	2024 S1
Net sales ¹	3,553	5,281	7,052	9,545
Change	-	48.63%	33.54%	35.35%
EBITDA ¹	1,345	1,792	1,978	2,627
Change	-	33.23%	10.38%	32.81%
EBIT ¹	1,319	1,761	1,934	2,441
Change	-	33.51%	9.82%	26.22%
Charge d'intérêts	-	-	-452	-
Earnings before Tax (EBT) ¹	1,846	3,101	2,009	3,843
Change	-	67.98%	-35.21%	91.29%
Net income ¹	1,402	2,356	1,583	2,733
Change	-	68.05%	-32.81%	72.65%
Announcement Date	11/08/21	10/08/22	03/08/23	08/08/24

¹DKK in Million

Estimates

Forecast Balance Sheet: Genmab A/S

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-16,079	-19,338	-22,324	-28,135	-21,101	-24,871	-30,719	-40,411
Change	-	-20.27%	-15.44%	-26.03%	25%	-17.87%	-23.51%	-31.55%
Announcement Date	23/02/21	16/02/22	22/02/23	14/02/24	12/02/25	-	-	-

¹DKK in Million

Estimates

Cash Flow Forecast: Genmab A/S

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	307	252	317	366	187	474.9	499	579.2
Change	-	-17.92%	25.79%	15.46%	-48.91%	153.94%	5.09%	16.06%
Free Cash Flow (FCF) ¹	6,126	1,976	3,595	7,014	7,584	6,347	7,903	9,342
Change	-	-67.74%	81.93%	95.1%	8.13%	-16.3%	24.51%	18.2%
Announcement Date	23/02/21	16/02/22	22/02/23	14/02/24	12/02/25	-	-	-

¹DKK in Million

Estimates

Forecast Financial Ratios: Genmab A/S

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	65%	38.51%	46.04%	34.09%	33.06%	34.97%	35.45%	38.52%
EBIT Margin (%)	62.44%	35.58%	43.56%	32.3%	32.53%	32.66%	33.42%	35.31%
EBT Margin (%)	58.39%	46.96%	48.2%	34.22%	42.57%	37.63%	37.64%	40.42%
Net margin (%)	47.06%	35.46%	37.83%	26.42%	36.44%	28.71%	29.12%	31.88%
FCF margin (%)	60.59%	23.3%	24.63%	42.58%	35.23%	26.91%	28.98%	29.64%
FCF / Net Income (%)	128.75%	65.69%	65.1%	161.17%	96.69%	93.73%	99.5%	92.95%
Profitability
ROA	26.22%	13.14%	20.11%	13.31%	19.34%	13.71%	14.17%	14.08%
ROE	28.69%	14.56%	22.25%	14.78%	22.97%	16.47%	16.59%	16.69%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	3.04%	2.97%	2.17%	2.22%	0.87%	2.01%	1.83%	1.84%
CAPEX / EBITDA (%)	4.67%	7.72%	4.72%	6.52%	2.63%	5.76%	5.16%	4.77%
CAPEX / FCF (%)	5.01%	12.75%	8.82%	5.22%	2.47%	7.48%	6.31%	6.2%
Items per share
Cash flow per share ¹	97.64	33.73	59.26	111.7	120.2	122	142.6	172.2
Change	-	-65.45%	75.68%	88.46%	7.65%	1.43%	16.91%	20.8%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	289.7	336.3	415.8	478.9	556	673.4	779.9	937.1
Change	-	16.08%	23.63%	15.19%	16.09%	21.11%	15.81%	20.16%
EPS ¹	72.21	45.54	83.65	66.02	121.4	103.2	120.5	150.8
Change	-	-36.93%	83.68%	-21.08%	83.82%	-14.94%	16.75%	25.17%
Nbr of stocks (in thousands)	65,410	65,423	65,362	65,322	63,524	61,590	61,590	61,590
Announcement Date	23/02/21	16/02/22	22/02/23	14/02/24	12/02/25	-	-	-